Rel-deficient_JJ
T_NN
cells_NNS
exhibit_VBP
defects_NNS
in_IN
production_NN
of_IN
interleukin_NN
3_CD
and_CC
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
._.

The_DT
c-rel_NN
protooncogene_NN
encodes_VBZ
a_DT
subunit_NN
of_IN
the_DT
NF-kappa_NN
B-like_JJ
family_NN
of_IN
transcription_NN
factors_NNS
._.

Mice_NNS
lacking_VBG
Rel_NN
are_VBP
defective_JJ
in_IN
mitogenic_JJ
activation_NN
of_IN
B_NN
and_CC
T_NN
lymphocytes_NNS
and_CC
display_VBP
impaired_JJ
humoral_JJ
immunity_NN
._.

In_IN
an_DT
attempt_NN
to_TO
identify_VB
changes_NNS
in_IN
gene_NN
expression_NN
that_WDT
accompany_VBP
the_DT
T-cell_NN
stimulation_NN
defects_NNS
associated_VBN
with_IN
the_DT
loss_NN
of_IN
Rel_NN
,_,
we_PRP
have_VBP
examined_VBN
the_DT
expression_NN
of_IN
cell_NN
surface_NN
activation_NN
markers_NNS
and_CC
cytokine_NN
production_NN
in_IN
mitogen-stimulated_JJ
Rel_NN
-_:
\/_NN
-_:
T_NN
cells_NNS
._.

The_DT
expression_NN
of_IN
cell_NN
surface_NN
markers_NNS
including_VBG
the_DT
interleukin_NN
2_CD
receptor_NN
alpha_NN
-LRB-_-LRB-
IL-2R_NN
alpha_NN
-RRB-_-RRB-
chain_NN
-LRB-_-LRB-
CD25_NN
-RRB-_-RRB-
,_,
CD69_NN
and_CC
L-selectin_NN
-LRB-_-LRB-
CD62_NN
-RRB-_-RRB-
is_VBZ
normal_JJ
in_IN
mitogen-activated_JJ
Rel_NN
-_:
\/_NN
-_:
T_NN
cells_NNS
,_,
but_CC
cytokine_NN
production_NN
is_VBZ
impaired_JJ
._.

In_IN
Rel_NN
-_:
\/_:
-_:
splenic_JJ
T_NN
cell_NN
cultures_NNS
stimulated_VBN
with_IN
phorbol_NN
12-myristate_NN
13-acetate_NN
and_CC
ionomycin_NN
,_,
the_DT
levels_NNS
of_IN
IL-3_NN
,_,
IL-5_NN
,_,
granulocyte-macrophage_JJ
colony-stimulating_JJ
factor_NN
-LRB-_-LRB-
GM-CSF_NN
-RRB-_-RRB-
,_,
tumor_NN
necrosis_NN
factor_NN
alpha_NN
-LRB-_-LRB-
TNF-alpha_NN
-RRB-_-RRB-
,_,
and_CC
gamma_NN
interferon_NN
-LRB-_-LRB-
IFN-gamma_NN
-RRB-_-RRB-
were_VBD
only_RB
2_CD
-_CD
to_TO
3-fold_RB
lower_JJR
compared_VBN
with_IN
normal_JJ
T_NN
cells_NNS
._.

In_IN
contrast_NN
,_,
anti-CD3_JJ
and_CC
anti-CD28_JJ
stimulated_JJ
Rel_NN
-_:
\/_:
-_:
T_NN
cells_NNS
,_,
which_WDT
fail_VBP
to_TO
proliferate_VB
,_,
make_VBP
little_JJ
or_CC
no_DT
detectable_JJ
cytokines_NNS
._.

Exogenous_JJ
IL-2_NN
,_,
which_WDT
restitutes_VBZ
the_DT
proliferative_JJ
response_NN
of_IN
the_DT
anti-CD3_NN
-_:
and_CC
anti-CD28-treated_JJ
Rel_NN
-_:
\/_:
-_:
T_NN
cells_NNS
,_,
restores_VBZ
production_NN
of_IN
IL-5_NN
,_,
TNF-alpha_NN
,_,
and_CC
IFN-gamma_NN
,_,
but_CC
not_RB
IL-3_NN
and_CC
GM-CSF_NN
expression_NN
to_TO
approximately_RB
normal_JJ
levels_NNS
._.

In_IN
contrast_NN
to_TO
mitogen-activated_JJ
Rel_NN
-_:
\/_NN
-_:
T_NN
cells_NNS
,_,
lipopolysaccharide-stimulated_JJ
Rel_NN
-_:
\/_:
-_:
macrophages_NNS
produce_VBP
higher_JJR
than_IN
normal_JJ
levels_NNS
of_IN
GM-CSF_NN
._.

These_DT
findings_NNS
establish_VBP
that_IN
Rel_NN
can_MD
function_VB
as_IN
an_DT
activator_NN
or_CC
repressor_NN
of_IN
gene_NN
expression_NN
and_CC
is_VBZ
required_VBN
by_IN
T_NN
lymphocytes_NNS
for_IN
production_NN
of_IN
IL-3_NN
and_CC
GM-CSF_NN
._.

